Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 4/20 | 0.48 |
| ▸ | TLR8 | Q9NR97 | 11/20 | 0.46 |
| ▸ | EP300 | Q09472 | 5/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27977634 | 1.00 | FGFR1 (0.48) | FGFR1TLR8EP300 | |
| SCHEMBL25628523 | 1.00 | FGFR1 (0.48) | FGFR1TLR8EP300 | |
| SCHEMBL13975422 | 1.00 | FGFR1 (0.48) | FGFR1TLR8EP300 | |
| SCHEMBL27723178 | 1.00 | FGFR1 (0.48) | FGFR1TLR8EP300 | |
| SCHEMBL13261399 | 0.98 | TLR8 (0.47) | FGFR1TLR8EP300 | |
| SCHEMBL19631097 | 0.93 | FGFR1 (0.45) | FGFR1TLR8EP300 | |
| SCHEMBL2967556 | 0.86 | FGFR1 (0.43) | FGFR1EP300 | |
| SCHEMBL23343373 | 0.86 | FGFR1 (0.44) | FGFR1EP300 | |
| SCHEMBL6551980 | 0.84 | FGFR1 (0.45) | FGFR1EP300 | |
| SCHEMBL8840764 | 0.83 | FGFR1 (0.41) | FGFR1EP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230399355-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2023-12-14 | — | — | US | disclosed |
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | Lakewood Amedex, Inc. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2023-01-26 | — | — | US | disclosed |
| CN-101341192-A | Supramolecular polymers | SECR DEFENCE (GB) | 2009-01-07 | — | — | CN | disclosed |
| US-20090005519-A1 | Supramolecular Polymers | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2009-01-01 | — | — | US | disclosed |
| US-20090005519-A1 | Supramolecular Polymers | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2009-01-01 | — | — | US | disclosed |
| EP-1966283-A1 | SUPRAMOLECULAR POLYMERS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007072000-A1 | SUPRAMOLECULAR POLYMERS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CAT, MPO, NISCH | FGFR1 4853/4885TLR8 423/4885EP300 3624/4885 |
| US-11795192-B2 | Antimicrobial compounds, compositions, and uses thereof | CAT, MPO, NISCH | FGFR1 4853/4885TLR8 423/4885EP300 3624/4885 |
| US-20230399355-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CAT, MPO, NISCH | FGFR1 4853/4885TLR8 423/4885EP300 3624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.